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Abstract
Background: Despite the progress in the Prevention of the Mother-to-Child Transmission of HIV (PMTCT), the
paediatric HIV epidemic remains worrying in Cameroon. HIV prevalence rate for the population of pregnant women
was 7.6 % in 2010 in Cameroon. The extent of the paediatric HIV epidemic is needed to inform policymakers. We
developed a stochastic simulation model to estimate the number of new paediatric HIV infections through MTCT
based on the observed uptake of services during the different steps of the PMTCT cascade in Cameroon in 2011.
Different levels of PMTCT uptake was also assessed.
Methods: A discrete events computer simulation-based approach with stochastic structure was proposed to
generate a cohort of pregnant women followed-up until 6 weeks post-partum, and optionally until complete
breastfeeding cessation in both prevalent and incident lactating HIV-infected women. The different parameters of
the simulation model were fixed using data sources available from the 2011 national registry surveys, and from
external cohorts in Cameroon. Different PMTCT coverages were simulated to assess their impact on MTCT. Available
data show a low coverage of PMTCT services in Cameroon in 2011.
Results: Based on a simulation approach on a population of 995, 533 pregnant women, the overall residual MTCT
rate in 2011 was estimated to be 22.1 % (95 % CI: 18.6 %–25.2 %), the 6-week perinatal MTCT rate among prevalent
HIV-infected mothers at delivery is estimated at 12.1 % (95 % CI: 8.1 %–15.1 %), with an additional postnatal MTCT
rate estimated at 13.3 % (95 % CI: 9.3 %–17.8 %). The MTCT rate among children whose mothers seroconverted
during breastfeeding was estimated at 20.8 % (95 % CI: 14.1 %–26.9 %). Overall, we estimated the number of new
HIV infections in children in Cameroon to be 10, 403 (95 % CI: 9, 054–13, 345) in 2011. When PMTCT uptake
have been fixed at 100 %, 90 % and 80 %, global MTCT rate failed to 0.9 % (95 % CI: 0.5 %–1.7 %), 2.0 % (95 % CI:
0.9 %–3.2 %) and 4.3 % (95 % CI: 2.4 %–6.7 %) respectively.
Conclusions: This model is helpful to provide MTCT estimates to guide the national HIV policy in Cameroon.
Increasing supply and uptake of PMTCT services among prevalent HIV infected pregnant women, as well as HIV-
prevention interventions including the offer and acceptance of HIV testing and counselling in lactating women
could reduce significantly the residual HIV MTCT in Cameroon. A public health effort should be made to encourage
health care workers and pregnant women to use PMTCT services until complete breastfeeding cessation.
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Background
It is estimated that 90 % of HIV infections in children are
resulting from mother-to-child-transmission (MTCT) [1].
By the end of 2011, of the 34 million adults infected with
HIV worldwide, 16 million were women [2]; in sub-
Saharan Africa, prevalence of HIV among pregnant
women is high. In the absence of any intervention to pre-
vent MTCT (PMTCT), the MTCT rate varies between
13 % and 48 % [1–3]. Maternal combination antiretroviral
therapy (ART) together with postnatal interventions have
demonstrated their efficacy in reducing substantially the
risk of MTCT in African breastfed children to less than
5 % [4, 5]. The World Health Organization (WHO) has
called for the “virtual elimination” of pediatric HIV [6, 7]
with the most efficient and cost-effective ways to tackle
paediatric HIV being to reduce MTCT worldwide [8].
However, access to ART and the uptake of PMTCT pro-
grams remain limited and children continue to be HIV-
infected [1].
In Cameroon, the prevalence of HIV was estimated to
be 4.3 % in the general population; a sero-surveillance
survey among pregnant women showed an HIV preva-
lence of 7.6 % in 2010 [9]. As a result the number of
new paediatric infections continues to grow in
Cameroon and there are still thousands of new infec-
tions each year [10]. In 2011, the UNAIDS launched the
Global Plan towards the elimination of new HIV infec-
tions among children and keeping their mothers alive
[7] making Cameroon, which overall MTCT risk was re-
ported to be around 24 % [7], one of the 21 priority
countries. Since 2011, Cameroon has tripled its coverage
of PMTCT prophylaxis, ranging from 6.9 % to 36.5 % in
2011, leading to 30 % fewer new HIV infections among
children [11]. In 2011, Cameroon opted for the WHO
Option A regimen for PMTCT prophylaxis. Continuing
access of pregnant women living with HIV to prenatal
HIV services and increasing access to HIV treatment for
eligible children and pregnant women will reduce mater-
nal and child mortality [11]. Cameroon has focused on
strengthening PMTCT services and caring of paediatric
HIV cases for the 2011–2015 period: 99.4 % of health
districts are equipped to provide HIV treatment services
for pregnant women and children living with HIV in
2011. However, even where the most effective PMTCT
interventions are available, many women and infants are
lost at different steps of the PMTCT cascade [12] and
the low cumulative uptake of PMTCT services does not
allow controlling the extent of MTCT in Cameroon.
Clinical trials and cohort studies provide essential infor-
mation in assessing PMTCT interventions; however these
studies are also very time and resource-consuming, diffi-
cult to implement and not representative. Alternatively,
simulation models can integrate available data and help to
project long-term outcomes. To date, several published
analyses have reported on simulation models to estimate
MTCT of HIV. Vieira et al. developed a discrete-event,
three-phase simulation, built in Visual Basic, with a sto-
chastic semi-Markov structure to model different inter-
vention strategies at any time, including short-course
antiretroviral drugs and cessation of breastfeeding in
Botswana [13]. Ciaranello et al. used local trial and pro-
grammatic data to simulate a cohort of HIV-infected,
pregnant/breastfeeding women in Zimbabwe and to com-
pare five PMTCT regimens at a fixed level of PMTCT
medication uptake. The authors linked published com-
puter simulation models to project clinical outcomes of
five PMTCT strategies [14]. Another simulation model for
MTCT is the Spectrum software package, developed by
Stover et al. [15–17]. The Spectrum program is used to
forecast key HIV prevalence and PMTCT rates based on
national HIV surveillance and surveys, program statistics
and epidemic patterns. To the best of our knowledge, to
date there are no published models that simulate individu-
ally a cohort of pregnant women in Cameroon able to esti-
mate MTCT rates accounting for both prevalent (infected
at delivery) and incident (infected in the lactating period)
maternal HIV infections. Thus, we developed a stochastic
simulation model to estimate the MTCT risk (perinatal
and postnatal) and the number of new paediatric infec-
tions based on the observed uptake of PMTCT pro-
grammes at different stages of the PMTCT cascade in
Cameroon in 2011. PMTCT uptake is an important deter-
minant of MTCT, we thus assessed the impact of increase
of PMTCT uptake at 100 %, 90 % and 80 % on the MTCT
of HIV in Cameroon.
Methods
We developed a discrete event computer simulation-based
approach with a stochastic structure to generate a hypo-
thetical cohort of pregnant women followed-up through
different states during pregnancy until 6-weeks postnatally
(perinatal transmission, which refers to all infections de-
tected prior to 6 weeks postpartum), and optionally until
complete weaning (prevalent and incident postnatal trans-
mission). Briefly there were 3 main health states: No HIV
infection, HIV-infection, and death. The HIV-infection state
were then subdivided into two sub-states :chronic HIV in-
fection (CD4 count ≥ 350 cells/mm3), acute HIV infection
(CD4 count < 350 cells/mm3 who themselves were divided
into sub-states according to breastfeeding, ART treatment
and/or PMTCT intervention. The fundamental unit of time
in the simulation was a month. Transition probabilities
from one state to another were constant over time and
based on observed data in Cameroon: the prevalence of
HIV, access to antenatal care, coverage of maternal HIV
testing, coverage of maternal CD4 cell count assessment
and live birth rate. The MTCT HIV transmission probabil-
ities depended on the timing of the mother’s infection
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(prior/during pregnancy or lactation), CD4 cell count at dif-
ferent stages, the ART regimen and duration and the
breastfeeding practices, thus the duration spent in each
health state (see Additional file 1 for detailed calculations).
Baseline input data
Baseline inputs used to characterize our hypothetical co-
hort of pregnant and lactating women were derived from
different data sources: current national surveys from
National AIDS Control Committee and Cameroon’s
National Institute of Statistics [18, 19], clinical trials and
cohort studies conducted in Cameroon or other resource-
limited settings in the absence of national data [20–23].
All data used are summarised in Table 1. We also assumed
that HIV infection is associated with a lower fertility
among HIV-infected women [24, 25]. The proportion of
live births issued from an HIV-infected woman was esti-
mated taking this fact into account, as well as the fact that
woman may die during pregnancy.
Model structure: calculation of mother-to-child transmission
probabilities
Mother-to-child-transmission (MTCT) of HIV can mainly
occur during the second and third trimester of pregnancy,
during delivery or breastfeeding [1]. Indeed, HIV transmis-
sion through breastfeeding has emerged as a substantial
mode of MTCT among African breastfeeding populations
and can occur in two different circumstances: among HIV
prevalent mothers HIV-infected at delivery and among inci-
dent mothers HIV-infected while lactating. The risk of
transmission through breastfeeding is cumulative according
to the duration of breastfeeding and the longer the duration
of breastfeeding, the greater the transmission risks [26–29].
Thus, we estimated three MTCT probabilities, using data
from MTCT studies among pregnant and breastfeeding
populations in Africa: 1/ the perinatal transmission prob-
ability at 6-week, 2/ the postnatal transmission probability
and 3/ the postnatal transmission probability in those born
to incident HIV-mothers who seroconverted while lactat-
ing. Additionally, we hypothesized that each of these three
MTCT probabilities varied according to the maternal age
group and CD4 count. Infants HIV status was computed
using these estimated MTCT probabilities.
Details regarding the calculation of live births rate
among HIV infected woman and the calculation of
MTCT probabilities are available in an additional text
file (see Additional file 1, which describes models used
for the calculation of MTCT probabilities and live birth
rate among HIV infected women).
Rates of mother-to-child transmission of HIV and population
size of new paediatric HIV infections
Using our model we simulated 1, 000 cohorts of the
population size of pregnant women expected in
Cameroon in 2011, through each state of the PMTCT
cascade described in Fig. 1.
We calculated, using a Monte Carlo approach simula-
tion, the MTCT rates including perinatal and postnatal
transmission rates among prevalent HIV-infected mothers
at birth and the postnatal transmission rate among inci-
dent mothers for these 1000 cohorts. We first modelled
the probability for a mother to infect her infant, used that
probability to estimate a number of HIV-infected infants
born to mothers in the simulated cohort and divided that
number by the number of children at risk of being HIV-
infected in that cohort. Specifically, the final MTCT risks
were calculated as follows: Perinatal transmission rate is
equal to the average number of HIV-infected children at
6-weeks born alive to prevalent HIV-infected mothers di-
vided by the total average number of live births from
prevalent HIV-infected mothers. Postnatal transmission
rate is equal to the average number of children HIV-
uninfected at 6-weeks who become infected beyond
through breastfeeding, divided by the total average
number of children born alive to prevalent and inci-
dent HIV-infected mothers. Postnatal transmission
rate due to incident infection among lactating
mothers: this rate is equal to the average number of
breastfed HIV-infected children born alive to mothers
HIV-uninfected at delivery but who seroconverted
during breastfeeding, divided by the total average
number of breastfed children born alive to incident
HIV-infected mothers. Population size of new paedi-
atric HIV infections is equal to the total average
number of live born children from an HIV-infected
prevalent mother at birth who become HIV-infected
perinatally or during the breastfeeding period and the
number of children HIV-infected through breastmilk
from an incident HIV-infected lactating mother.
Finally, we examined the impact of different levels of
uptake of PMTCT services on the MTCT rates and the
number of new paediatric infections. Three scenarios were
considered. First, we considered 100 % uptake and with a
100 % retention on treatment during the whole breast-
feeding period. This meant that all pregnant women had
access to antenatal care (ANC), HIV testing and counsel-
ling, disclosure of their HIV results; those who were in-
fected had a CD4 assessment and were initiated on ART
prophylaxis during pregnancy until the end of breastfeed-
ing, as well for their child. In the second scenario, we con-
sidered a 90 % uptake of PMTCT services, described as
100 % access to ANC, 90 % HIV testing and counselling, a
100 % of HIV testing result disclosure and a 90 % rate of
ART prophylaxis during pregnancy. The third scenario
meant 80 % uptake of PMTCT services, described as
100 % access to ANC, 80 % HIV testing and counselling, a
100 % of HIV testing result disclosure and an 80 % rate of
ART prophylaxis during pregnancy.
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Table 1 Pregnant women population groups and model key parameters according to the observed data in the different age groups
Age groups (years) 15–49 15–19 20–24 25–29 30–34 35–39 40–44 45–49 Data source
Total number of pregnant women expected 995, 533 231, 982 202, 093 173, 223 125, 437 108, 513 80, 638 73, 647 Cameroon [18, 19]
HIV prevalence, % 5.6 2.0 3.4 7.6 7.3 10.0 7.1 6.4 Cameroon [18]
Access to Antenatal Care), % 36.5 Cameroon [19]
Prenatal HIV testing, % 29.3 Cameroon [19]
Receipt of maternal HIV test result, % 92.4 Cameroon [19]
Mortality during pregnancy, % 4 Cameroon [19]
Live birth among HIV uninfected women, % 95 Cameroon [9, 19]
Live birth among HIV infected women, % 94.6 72.7 68.9 63.3 58.4 52.0 51.9 [17, 26]
ARV prophylactic coverage for HIV infected pregnant women, % 20.3 Cameroon [19]
CD4 cell count quantification for HIV infected women, % 6.9 Cameroon [19]
Pregnant women ART eligible in ANC, % 60 Cameroon [19]
ART coverage for eligible women in ANC, % 25 Cameroon [19]
HIV MTCT rate at 6-week in the absence of MTCT, % 22 Sub-saharan Africa [23, 28]
Treatment Effectiveness Expected [21, 23]
-Short course ARV (% reduction) 86.7
-Long course ARV/ ART (% reduction) 93.7
Rate of breastfeeding exposure among HIV exposed children known
at birth (%)
46 Cameroon, Pediacama 1, CIRCB field studiesb
Rate of breastfeeding exposure among children not known to be HIV
exposed at birth, (%)
97 Cameron [18]
Intra-partum incidence of HIV infection (per 100 woman-year
of follow-up), %
2 2 1.6 1.3 1 0.6 0.6 Sub-saharan Africa [39–41]
Incident HIV infections among lactating women, % 2.0 Zimbabwe [27, 31]
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Proportion of HIV exposed children who received postnatal ART, % 9.2 Cameroon [19]




ANC antenatal care, ART antiretroviral therapy, ARV antiretroviral, MTCT mother-to-child transmission; aPediacam is a multisite cohort study started in Cameroon in November 2007 with two main objectives: to study
the feasibility and effectiveness, of early antiretroviral multi-therapy offered systematically to HIV-infected infants before 7 months of age; and to evaluate the humoral response of these children to vaccines of the














Fig. 1 PMTCT cascade. This figure shows the different state between pregnancy and delivery, then delivery and breastfeeding cessation,
including PMTCT services offering: gray colour highlights the missed opportunities in the PMTCT process. Each oval represents a maternal health
state, rounded rectangle represents child health state and rectangle represents clinical events and breastfeeding practices
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95 % confidence intervals of perinatal, postnatal and
postnatal due to maternal incident infection rates, as
well as the population size of new paediatric infections
were derived from the 0.025 and 0.975 quintiles of 1000
subpopulation generated by bootstraps.
Sensitivity analyses
Sensitivity analyses of the results of the simulation
model were conducted by varying in suitable intervals
some key parameters in the prevention of MTCT of
HIV, as described in Table 2. Sensitivity analyses were
performed by varying these parameters in specific inter-
vals based on the lowest and highest published values.
For each key parameter 1000 values were randomly drew
within the corresponding range. For each of these 1000
sets of randomly drawn parameter we simulated one co-
hort of the population size of pregnant women expected
in Cameroon in 2011 and the associated MTCT rates
were calculated.
In this work, all results were performed using R statis-
tical software (R Core Team (2013). R: A language and
environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. URL http://
www.R-project.org/.).
Results
The simulation model was performed for the population
of 995, 533 pregnant women expected in Cameroon in
2011 [19].
Base-case analyses: fixed values of PMTCT cascade
Available data showed a low rate of PMTCT services
utilization (i.e. uptake of all components of the PMTCT
cascade) everywhere in Cameroon, ranging from 6.9 %
to 36.5 % in 2011 [19].
Table 3 presents the results of simulated mother-to-
child transmission rates of HIV in both prevalent and
incident HIV-infected mothers according to the ob-
served coverage of PMTCT services in Cameroon in
2011. The overall MTCT rate, in both prevalent and in-
cident HIV-infected mothers, was estimated to be
22.1 % (95 % Confidence Interval (CI): 18.6 %–25.2 %)
in 2011, resulting in 10, 403 new paediatric HIV infec-
tions (95 % CI: 9, 054–13, 345).
Estimates of the perinatal MTCT rate was 12.1 %
(95 % CI: 8.1 %–15.1 %), leading to 3, 758 new paediatric
infections at 6-week of life (95 % CI: 3, 033–5, 077).
During the postnatal period, the MTCT rate issued from
prevalent HIV-infected women at delivery was 13.3 %
(95 % CI, 9.3 %–17.8 %) corresponding to 3, 484 (95 %
CI: 2, 687–5, 286) new paediatric infections. Among
mothers who seroconverted during the breastfeeding
period, the postnatal MTCT reached 20.8 % (95 % CI:
14.1 %–26.9 %), corresponding to 3, 161 (95 % CI: 2,
337–4, 679) new paediatric infections.
Different PMTCT utilization coverage
Table 4 presents the results of three simulated scenarios
of MTCT rates of HIV and number of new infections in
prevalent maternal population according to the observed
coverage of PMTCT services in Cameroon in 2011in
case of 100 %, median 90 % and more likely of 80 % up-
take of PMTCT services.
When the model was run for a 100 % level of con-
sumption of PTMCT services among prevalent HIV
pregnant women, we estimated the MTCT rate of HIV
at 6-weeks to be 0.4 % (95 % CI: 0.2 %–1.1 %), corre-
sponding to 165 (95 % CI: 99–398) new paediatric peri-
natal infections. The postnatal transmission rate would
be 0.8 % (95 % CI: 0.5 %–1.6 %), corresponding to 149
(95 % CI: 99–298) new paediatric postnatal infections.
Thus, the global MTCT rate issued from prevalent HIV
infected mothers would be 0.9 % (95 % CI: 0.5 %–1.7 %),
Table 2 Range of Model parameters for sensitivity analyses (results expressed in %)
Key parameters Base case value Range for sensitivity analyses Data sources
Access to ANC 36.5 36–85 [18, 19]
HIV testing in ANC 80.1 80–100 [19]
ARV prophylactic coverage in ANC for HIV-infected women 67 50–74 [2, 19]
CD4 cell count quantification for infected women in ANC 22.9 22–100 [19]
ART eligible in ANC 60 40–60 [19]
ART coverage for eligible women in ANC 25 25–32 [3, 19]
Natural history of HIV MTCT at birth 22 15–25 [23, 28]
Treatment Effectiveness [21, 23]
-Short course ARV (reduction) 86.7 86–95
-Long course ARV/ ART (reduction) 93.7 93–95
Incidence rate among postpartum lactating women 2.0 0.2–3.8 [31]
ANC antenatal care, ART antiretroviral therapy, ARV antiretroviral treatment, MTCT mother-to-child transmission
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with a total number of new paediatric infections of 316
(95 % CI: 198–631).
Assuming that PMTCT services were used at 90 %,
the MTCT rate of HIV at 6-weeks would be 1.4 % (95 %
CI: 0.5 %–2.8 %), corresponding to 509 (95 % CI: 199–
995) new paediatric perinatal infections, and the postna-
tal transmission rate would be 1.3 % (95 % CI: 0.5 %–
3.0 %), corresponding to 205 (95 % CI: 99–497) new
paediatric postnatal infections. In this scenario, the glo-
bal MTCT rate issued from prevalent HIV-infected
mothers would be 2.0 % (95 % CI: 0.9 %–3.2 % with a
total of new paediatric infections reaching 711 (95 % CI:
306–1, 187).
When running the model for a 80 % uptake of
PTMCT services, the MTCT rate at 6-weeks would be
3.3 % (95 % CI: 1.3–5.6), corresponding to 1, 150 (95 %
CI: 497–1, 891) new paediatric perinatal infections, and
the postnatal transmission would be 2.1 % (95 % CI:
0.6 %–4.4 %) corresponding to 342 (95 % CI: 99–696)
new paediatric postnatal infections. In this scenario, the
global MTCT rate issued from prevalent HIV infected
mothers would 4.3 % (95 % CI: 2.4 %–6.7 %), with a total
number of new paediatric infections to be 1, 505 (95 %
CI: 895–2, 354).
Hence, for prevalent HIV-infected mothers, reaching
100 % uptake of PMTCT services would lead to a 96.9 %
(95 % CI: 93.9 %–98.0 %) reduction of new paediatric in-
fections in 2011. When PMTCT services are used at
90 %, the new paediatric infections rate would be reduce
by 93.1 % (95 % CI: 88.5 %–97.0 %) and by 85.5 % (95 %
CI: 77.3 %–91.3 %) if PMTCT services are used at 80 %.
Sensitivity analyses
When varying identified key parameters in the model,
the mean perinatal transmission rate was 10.6 % (95 %
CI: 6.2 %–15.5 %), the mean postnatal transmission rate
among prevalent mothers was 12.3 % (95 % CI: 8.1 %–
16.5 %) and the mean postnatal transmission rate among
incident HIV-infected lactating mothers was 20.1 %
(95 % CI, [11.3–29.5]). The population size of new
Table 3 Simulated MTCT rates of HIV in prevalent and incident maternal population according to the observed coverage of PMTCT
services in Cameroon in 2011
MTCT circumstances Estimated number of incident paediatric
infections [95 % Confidence Interval]
Estimated transmission rate (%)
Prevalent HIV-infected pregnant women
Perinatal rate (<6 weeks of age) 3, 758 [3, 033–5, 077] 12.1 [8.8–15.1]
Postnatal rate (>6 weeks of age to 24 months) 3, 484 [2, 687–5, 286] 13.3 [9.3–17.8]
Postnatal rate among incident maternal infection during breastfeeding 3, 161 [2, 337–4, 679] 20.8 [14.1–26.9]
Total 10, 403 [9, 054–13, 345] 22.1 [18.6–25.2]
MTCT mother-to-child transmission, PMTCT prevention of mother-to-child transmission
Table 4 Simulated scenarios of MTCT rates of HIV in prevalent maternal population according to the fixed coverage of PMTCT
services in Cameroon in 2011
100 % of PMTCT services coverage
MTCT circumstances Estimated number of incident paediatric infections
[95 % Confidence Interval]
Estimated transmission rate (%)
Perinatal rate (<6 weeks of age) 165 [99–398] 0.4 [0.2–1.1]
Postnatal rate (>6 weeks of age to 24 months) 149 [99–298] 0.8 [0.5–1.6]
Total 316 [198–631] 0.9 [0.5–1.7]
90 % of PMTCT services coverage
Perinatal rate (<6 weeks of age) 509 [199–995] 1.4 [0.5–2.8]
Postnatal rate (>6 weeks of age to 24 months) 205 [99–497] 1.3 [0.5–3.0]
Total 711 [306–1, 187] 2.0 [0.9–3.2]
80 % of PMTCT services coverage
Perinatal rate (<6 weeks of age) 1, 150 [497–1, 891] 3.3 [1.3–5.6]
Postnatal rate (>6 weeks of age to 24 months) 342 [99–696] 2.1 [0.6–4.4]
Total 1, 505 [895–2, 354] 4.3 [2.4–6.7]
MTCT mother-to-child transmission PMTCT prevention of mother-to-child transmission
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paediatric infections in 2011 was 9, 131 cases (95 % CI:
4, 279–14, 834). Simulating improvements in coverage
of prenatal services, prenatal HIV testing, CD4 cell
count assessment among HIV-infected ARV for eligible
women, PMTCT prophylactic services, improvement of
treatment effectiveness, and the reduction of the inci-
dence of HIV among lactating women led to the reduc-
tion of perinatal and postnatal transmission rates.
Discussion
We developed a discrete event simulation model with a
stochastic structure to estimate the rates of MTCT of
HIV and the number of new paediatric HIV infections in
2011 in Cameroon cumulating the two situations of
prevalent HIV-infected mothers at delivery and incident
HIV-infected mothers while lactating. First, despite the
PMTCT services implementation, we still observed in
2011 an overall residual global MTCT rate that reached
22 %. Second, in this context of PMCT interventions,
our results highlight that most of paediatric HIV infec-
tions occurred postnatally, through breastfeeding, and
this was particularly high among the mothers who ac-
quired HIV during lactation. Finally, in scenarios where
the uptake of PMTCT is high i.e.100 %, 90 % and 80 %,
we could reach significant reductions of MTCT by
96.6 %, 93.1 % and 85.5 % respectively.
The results of this simulation model report an overall
MTCT risk of 22 % in 2011 which remains high and
consistent with the 24 % reported by the UNAIDS’ Glo-
bal Plan that same year [7, 30]. We explain this high rate
by a limited access to PMTCT interventions coupled
with a low uptake of these services at different steps of
the PMTCT cascade. Despite efforts towards eliminating
new paediatric infections, Cameroon still faces limited
availability of PMTCT services in primary health-care
centres. In 2011, the country opted for the WHO Op-
tion A regimen for PMTCT prophylaxis. However, only
20 % of identified HIV-infected pregnant women re-
ceived a PMTCT prophylaxis [19], and 27 % of their in-
fants received a postnatal ART for prophylaxis [30]. It is
urgent to expand the availability of PMTCT services
within ANC and to improve the retention and access to
services delivery over the whole MTCT period at risk,
i.e. until the complete cessation of breastfeeding.
In our study, we also found that the risk of MTCT
was highest in women who acquired HIV infection in
the post-partum period. This result has already been re-
ported in other settings [27]. Indeed, a study conducted
in Zimbabwe showed that MTCT was 4.6 times higher
in mothers who had seroconverted during breastfeeding
compared to those who had been tested HIV-positive
prior to delivery [27]. We explain this by a peak of ma-
ternal breast-milk viral load after the maternal HIV
primo-infection [27, 31]. In our model, maternal
infection during breastfeeding contributed significantly,
for one-third, to the paediatric HIV burden. This result
has been reported by other modelling studies, including
one in South Africa where the proportion of MTCT was
26 % in mothers who seroconverted after their first ANC
visit [32, 33]. Another survey conducted in Mozambique,
reported an MTCT rate in mothers who seroconverted
during breastfeeding of 21 % [34]. Nevertheless, despite a
high HIV post-partum incidence in high prevalence set-
tings in Africa, the HIV testing coverage in women in late
pregnancy or in the postpartum period remains uncom-
mon as testing practices often focus on the first ANC. In
high HIV prevalence settings, early identification of inci-
dent infection in postpartum women and immediate test-
ing of their exposed children is critical for initiating ART
prophylaxis to prevent infection in infants and initiating
early ART for those HIV-infected infants. Repeated HIV
testing of HIV-uninfected mothers around delivery could
allow identifying newly infected women and their exposed
infants [35]. However, in resource-limited settings, the
turnover period of these tests is often counted in weeks
and the mother has already infected her child. In this con-
text, it is primarily essential to focus on developing in-
novative primary HIV prevention programmes targeted
on breastfeeding women and their partners [36]. Strategies
to control postnatal MTCT should include community,
behavioural and biomedical interventions focused to the
vulnerable population of breastfeeding women.
According to the different PMTCT utilization rate sce-
narios analysed, we also demonstrated that the Global
Plan target of reducing new paediatric infections by
90 % could be achieved if all pregnant women used
PMTCT services at each step of the PMTCT cascade.
This result is consistent with another modelling study
conducted using the Spectrum model, that reported a
reduction of 79 % in new paediatric infections in 25
countries, including Cameroon [37]. Decreasing mark-
edly HIV MTCT transmission rates and eliminating new
infections requires achieving family planning, primary
HIV prevention of childbearing age women, and univer-
sal coverage of effective prenatal and postnatal antiretro-
viral regimen. In practice, Cameroon has achieved
considerable progress, and in 2012, the ART coverage
for PMTCT was estimated to be 64 % [11]. Furthermore,
Cameroon started implementing Option B+ at the na-
tional level in 2014. Indeed, most of the efforts on
PMTCT have been focused on improving access to pre-
natal antiretroviral prophylaxis. However, antiretroviral
prophylaxis alone is insufficient and it is essential to im-
prove the primary prevention and access to family plan-
ning. According to the Cameroon demographic health
survey, 24 % of women still have unmet needs for family
planning [18]. Modelling studies have suggested that
there will be significant reductions in the number of
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HIV-exposed infants if unmet needs are reduced [37].
Thus, it is essential to strengthen programmes that offer
family planning services to both HIV-infected and unin-
fected pregnant women.
Methods for producing estimates have their limitations
[38]. First, computer simulations simplify complex bio-
logical and operational processes and many assumptions
involved some uncertainty. However, our results are con-
sistent with those previously reported by other modelling
studies, including the Spectrum model. Second, we used
multiple-source data from different settings that were not
all issued from Cameroon. This may have also impacted
our assumptions in the estimation of transition probabil-
ities between states. However, sensitivity analyses con-
ducted found that the impact on estimates was minimal.
In the other hand, our model don’t take into account of
maternal death during up to two months postpartum
period. Consequently, the number of new paediatric HIV
infections due to postnatal transmission could be overesti-
mated in our model. Finally, in this analysis, we did not
consider different PMTCT antiretroviral regimens. Indeed,
it is still largely unclear which option is the most effective
when implemented in a public healthcare system, but we
felt that our average estimate of efficiency was likely [37].
The originality of this work is that most of the input
PMTCT services and coverage components were is-
sued from the Cameroon, which provides here a use-
ful estimation of the paediatric infections projections
for policymakers at the national level. The data pre-
sented here represent a base case scenario against
which we will compare more recent estimates as they
become available, reflecting other interventions as
they are implemented, including option B+ regimen
for PMTCT prophylaxis.
Conclusion
Despite access to PMTCT services, paediatric HIV infec-
tions remain a concerning problem in Cameroon in 2011,
with a high residual MTCT rate attributable to postnatal
transmission. The national strategies planned to increase
the PMTCT services coverage among HIV-exposed chil-
dren, pregnant and lactating HIV-infected women to at
least 90 % for the 2011–2015 periods to substantially re-
duce new infant HIV infections. However, to reach the goal
of the ‘virtual elimination’ of paediatric HIV, the national
strategic plan needs to first fix ANC access and delivery of
antenatal HIV testing to 100 % for prevalent HIV-infected
mother before delivery. An additional effort should be
made to encourage pregnant women to use PMTCT ser-
vices at all levels, at least until a complete breastfeeding ces-
sation. Then, a substantial effort needs to be done to
prevent HIV incidence in lactating women. This recurrent
modelling informed by the national statistics will be helpful
in guiding the national policy to PMTCT in Cameroon.
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